These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 37111688)
1. Cabello-Olmo M; Oneca M; Urtasun R; Pajares MJ; Goñi S; Riezu-Boj JI; Milagro FI; Ayo J; Encio IJ; Barajas M; Araña M Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111688 [TBL] [Abstract][Full Text] [Related]
2. Antidiabetic Effects of Cabello-Olmo M; Oneca M; Pajares MJ; Jiménez M; Ayo J; Encío IJ; Barajas M; Araña M Nutrients; 2022 Feb; 14(3):. PubMed ID: 35277051 [TBL] [Abstract][Full Text] [Related]
3. Glucose-lowering effects of a synbiotic combination containing Pediococcus acidilactici in C. elegans and mice. Yavorov-Dayliev D; Milagro FI; Ayo J; Oneca M; Goyache I; López-Yoldi M; Aranaz P Diabetologia; 2023 Nov; 66(11):2117-2138. PubMed ID: 37584728 [TBL] [Abstract][Full Text] [Related]
4. Yavorov-Dayliev D; Milagro FI; López-Yoldi M; Clemente I; Riezu-Boj JI; Ayo J; Oneca M; Aranaz P Food Funct; 2023 Dec; 14(24):10855-10867. PubMed ID: 37987083 [TBL] [Abstract][Full Text] [Related]
5. Yavorov-Dayliev D; Milagro FI; Ayo J; Oneca M; Aranaz P Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269839 [TBL] [Abstract][Full Text] [Related]
6. Mucosa-associated microbiota in the jejunum of patients with morbid obesity: alterations in states of insulin resistance and metformin treatment. Gutiérrez-Repiso C; Moreno-Indias I; Martín-Núñez GM; Ho-Plágaro A; Rodríguez-Cañete A; Gonzalo M; García-Fuentes E; Tinahones FJ Surg Obes Relat Dis; 2020 Oct; 16(10):1575-1585. PubMed ID: 32475753 [TBL] [Abstract][Full Text] [Related]
7. Rapamycin/metformin co-treatment normalizes insulin sensitivity and reduces complications of metabolic syndrome in type 2 diabetic mice. Reifsnyder PC; Flurkey K; Doty R; Calcutt NA; Koza RA; Harrison DE Aging Cell; 2022 Sep; 21(9):e13666. PubMed ID: 35986566 [TBL] [Abstract][Full Text] [Related]
8. Zhang Q; Guo WL; Chen GM; Qian M; Han JZ; Lv XC; Chen LJ; Rao PF; Ai LZ; Ni L Curr Res Food Sci; 2022; 5():775-788. PubMed ID: 35520273 [TBL] [Abstract][Full Text] [Related]
10. Comparative Evaluation of the Effect of Metformin and Insulin on Gut Microbiota and Metabolome Profiles of Type 2 Diabetic Rats Induced by the Combination of Streptozotocin and High-Fat Diet. Hu N; Zhang Q; Wang H; Yang X; Jiang Y; Chen R; Wang L Front Pharmacol; 2021; 12():794103. PubMed ID: 35046817 [TBL] [Abstract][Full Text] [Related]
11. Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus. Bermúdez-Pirela VJ; Cano C; Medina MT; Souki A; Lemus MA; Leal EM; Seyfi HA; Cano R; Ciscek A; Bermúdez-Arias F; Contreras F; Israili ZH; Hernández-Hernández R; Valasco M Am J Ther; 2007; 14(2):194-202. PubMed ID: 17414590 [TBL] [Abstract][Full Text] [Related]
12. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Shin NR; Lee JC; Lee HY; Kim MS; Whon TW; Lee MS; Bae JW Gut; 2014 May; 63(5):727-35. PubMed ID: 23804561 [TBL] [Abstract][Full Text] [Related]
13. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. Balakumar M; Prabhu D; Sathishkumar C; Prabu P; Rokana N; Kumar R; Raghavan S; Soundarajan A; Grover S; Batish VK; Mohan V; Balasubramanyam M Eur J Nutr; 2018 Feb; 57(1):279-295. PubMed ID: 27757592 [TBL] [Abstract][Full Text] [Related]
14. A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice. Gao LH; Liu Q; Liu SN; Chen ZY; Li CN; Lei L; Sun SJ; Li LY; Liu JL; Shen ZF J Ethnopharmacol; 2014; 151(1):675-85. PubMed ID: 24286962 [TBL] [Abstract][Full Text] [Related]
15. Effect of chronic p,p'-dichlorodiphenyldichloroethylene (DDE) exposure on high fat diet-induced alterations in glucose and lipid metabolism in male C57BL/6H mice. Howell GE; Mulligan C; Meek E; Chambers JE Toxicology; 2015 Feb; 328():112-22. PubMed ID: 25541407 [TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of metformin supplementation in hypothalamic paraventricular nucleus and arcuate nucleus of type 2 diabetic rats. Yu XJ; Chen YM; Liu XJ; Bai XJ; Liu KL; Fu LY; Gao HL; Sun TZ; Shi XL; Qi J; Li Y; Kang YM Toxicol Appl Pharmacol; 2022 Feb; 437():115893. PubMed ID: 35085591 [TBL] [Abstract][Full Text] [Related]
17. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study. Heeba GH; El-Deen RM; Abdel-Latif RG; Khalifa MMA Can J Physiol Pharmacol; 2020 Aug; 98(8):498-505. PubMed ID: 32083947 [TBL] [Abstract][Full Text] [Related]
18. Genomic analysis and in vivo efficacy of Pediococcus acidilactici as a potential probiotic to prevent hyperglycemia, hypercholesterolemia and gastrointestinal infections. Al-Emran HM; Moon JF; Miah ML; Meghla NS; Reuben RC; Uddin MJ; Ibnat H; Sarkar SL; Roy PC; Rahman MS; Alam ASMRU; Islam OK; Jahid IK Sci Rep; 2022 Nov; 12(1):20429. PubMed ID: 36443433 [TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rb1 protects against diabetes-associated metabolic disorders in Kkay mice by reshaping gut microbiota and fecal metabolic profiles. Zhou R; He D; Zhang H; Xie J; Zhang S; Tian X; Zeng H; Qin Y; Huang L J Ethnopharmacol; 2023 Mar; 303():115997. PubMed ID: 36509256 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic Effects of SGLT2 Inhibitor Ipragliflozin and Metformin on NASH in Type 2 Diabetic Mice. Tahara A; Takasu T Endocr Res; 2020; 45(2):147-161. PubMed ID: 31955626 [No Abstract] [Full Text] [Related] [Next] [New Search]